Earnings Call · Q3 FY2022·2022-11-02

Q3 22EPS +70.83%·Rev n/aQ2 22EPS +16.67%·Rev n/aQ1 22EPS +57.58%·Rev n/aQ4 21EPS -100.00%*·Rev n/a⚠ consensus missing

10x Genomics, Inc. TXG

Cassie Corneau — Investor Relations

Serge Saxonov — Chief Executive Officer

Justin McAnear — Chief Financial Officer

+18.5%1d on move date+19.5% vs SPY3d+14.8%5d+13.0%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more TXG calls or request research access.

More TXG calls Browse calls Request research access